Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for healthcare industry professionals · Friday, March 23, 2018 · 438,516,205 Articles · 3+ Million Readers

Translational Medicine: A need based multi-disciplinary community approach to ailments - OMICS Group Medical Conferences

2nd International Conference on Translational Medicine 2013

2nd International Conference on Translational Medicine 2013

2nd International Conference on Translational Medicine to be held during August 5-7, 2013 in Chicago-North Shore, USA.

LOS ANGELES, CA, July 11, 2013 / -- Malnutrition is a socio, economic and cultural problem that requires a sustained, multi dimensional intervention. Children of the developing and the less developed countries of the world are worst hit due to malnutrition that may cause among other things, poor body weight, which is not in proportion to the child’s age, falling prey to diseases because of poor immune system and lack of physical and mental development.

Diseases that develop as a result of insufficient feeding cannot be treated merely by administering medicines alone and it rather demands a multi- disciplinary approach, capable of finding the root cause of the problem so that the expected solutions can be attained.

Translational medicine is an approach to address the health ailments that arise as a result of certain poor practices. Malnutrition for example is a result of extreme poverty, lack of safe drinking water, unhygienic surroundings, and utter lack of awareness on how to tackle it effectively. Several health ailments like diarrhea, common cold, fever and other communicable diseases may be prevalent among the children that are affected by malnutrition. There should be a sustainable effort in addressing the root cause of the problem by providing sufficient income generating opportunities to the communities so that families can afford to have healthy meal to their children. This should be followed by certain other efforts like creating awareness on aspects like personal hygiene, necessity to keep their surroundings clean and tidy so that communities can arrest the spread of diseases. The multi-dimensional approach to treat diseases using the knowledge gathered from various sources, inclusive of medicines is called as Translational Medicine.

It is relatively a very young area of biomedicine that pharmacy companies deploying to provide a patient driven approach to drug development. It transforms the laboratory findings into new and innovative ways to treat patients. Translational medicine (TM) focuses on applying what is learned at pre-clinical learning to clinical level. TM helps in predicting, preventing, diagnosing, and treating diseases effectively by applying non-clinical research findings.

OMICS Group that champions for the cause of knowledge dissemination using open access journals and its series of conferences takes pride in announcing the 2nd International Conference on Translational Medicine to be held during August 5-7, 2013 in Chicago-North Shore, USA.

Translational Medicine Conference 2013 aims at bringing representatives from the industry, government and leading academic research institutions together to discuss on advancement of early stage research to clinical treatments.

This meet also covers current and emerging challenges in the biopharmaceutical industry and strategies for drug development. Current strategies and processes for drug discovery and development within the pharmaceutical industry are contrasted with the adoption of Translational Medicine research.

Translational Medicine-2013 focuses on aspects like building an effective mechanism to deliver advancements of research to patients, and addressing the contrasting requirements for effective translation in commercial companies and health services. It tries to integrate a cross section of fields like science, medicine and socio-economic disciplines.

Confirmed Speakers of Translational Medicine 2013 include

• Immanuel Freedman, GlaxoSmithKline, USA
• Michael Retsky, Harvard School of Public Health, USA
• Paul Frohna, Frohna Biotech Consulting, USA
• Dan Housman, Recombinant by Deloitte, USA
• Jingfang Ju, Stony Brook University, USA
• Jamboor K. Vishwanatha, University of North Texas Health Science Center, USA
• Ann-Marie Chacko, University of Pennsylvania, USA
• Paul Hwang, University of Toronto, Canada
• Sevtap Savas, Memorial University of Newfoundland, Canada
• Wanda Sicinska, University of Warsaw, Poland
• Antonio Gomez-Munoz, Universidad del Pais Vasco, Spain
• P. Yuan, Lee Ming Institute of Technology, China

For more details on Translational Medicine-2013 conference, please visit:

For further details contact
Katherine Zara
Translational Medicine-2013 Organizing Committee
OMICS Group Medical Conferences
5716 Corsa Ave, Suite110
Westlake, Los Angeles
CA-91362-7354, USA
Office Ph: +1-888-843-8169
Toll No +1-800-216-6499(USA & Canada)
Email (or)

Katherine Zara
OMICS Group Medical Conferences
email us here